Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO

W. Oliver Tobin, Brian G. Weinshenker

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO'. Together they form a unique fingerprint.